NCT04098848

Brief Summary

To determine the effect of intradialytic cycling exercise on fatigability, sleep disorders, arterial stiffness and endothelial function in dialysis patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 15, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 23, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

March 2, 2022

Status Verified

March 1, 2022

Enrollment Period

3 years

First QC Date

September 15, 2019

Last Update Submit

March 1, 2022

Conditions

Outcome Measures

Primary Outcomes (8)

  • Change of the Functional Assessment of Chronic Illness Therapy -Fatigue (FACIT-F) score for 2 years

    Compare the FACIT-F score before, during and after intradialytic cycling exercise FACIT-F score is from 0-52 points; higher score represents less fatigue.

    pre-test and then every 3 months for 2 years

  • Change of the Pittsburgh Sleep Quality Index (PSQI) score for 2 years

    Compare the PSQI score before, during and after intradialytic cycling exercise PSQI score is from 0-21 points; score\>=5 means poor sleeping quality.

    pre-test and then every 3 months for 2 years

  • Change of the carotid-femoral pulse wave velocity (cfPWV) for 2 years

    Compare the cfPWV before, during and after intradialytic cycling exercise cfPWV measurement: a measure of aortic wall stiffness, increases markedly with age. Each set of pulse wave and ECG data to calculate the mean time difference between R-wave and pulse wave on a beat-to-beat basis, with an average of 10 consecutive cardiac cycles. The cfPWV will be calculated using the distance and mean time difference between the two recorded points. Patients with cfPWV values of \> 10 m/s were classified in the high arterial stiffness group, whereas those with cfPWV values of ≤10 m/s were assigned to the low arterial stiffness group.

    pre-test and then every 3 months for 2 years

  • Change of the cardio-ankle vascular index (CAVI) for 2 years

    Compare the CAVI before, during and after intradialytic cycling exercise CAVI is a novel and accurate method, independent of the effect of blood pressure, and is used as a predictor of arterial stiffness (AS) AS was defined as a CAVI ≥ 9

    pre-test and then every 3 months for 2 years

  • Change of the brachial-ankle pulse wave velocity (baPWV) for 2 years

    Compare the baPWV before, during and after intradialytic cycling exercise baPWV is one measure arterial stiffness using brachial to ankle arterial wave analyses and has been used to assess peripheral arterial stiffness (PAS) baPWV value \>14.0 m/s on either side was considered high PAS.

    pre-test and then every 3 months for 2 years

  • Change of the aortic augmentation index(AI) measurements for 2 years

    Compare the AI before, during and after intradialytic cycling exercise AI of central blood pressure have been widely used as clinical indices of arterial stiffness AI is an indirect measure of central arterial stiffness, but mainly a direct measure of central wave reflection

    pre-test and then every 3 months for 2 years

  • Change of the brachial flow-mediated vasodilatation (bFMD) for 2 years

    Compare the bFMD before, during and after intradialytic cycling exercise Endothelial function is often quantified by FMD, which represents the endothelium-dependent relaxation of a conduit artery-typically the brachial artery - due to an increased blood flow.

    pre-test and then every 3 months for 2 years

  • Change of the digital thermal monitoring (DTM) for 2 years

    Compare the DTM before, during and after intradialytic cycling exercise DTM is a simple noninvasive method to measure endothelial function and vascular reactivity that is correlated with atherosclerosis risk factors and coronary artery disease Vascular reactivity index (VRI) \< 1.0: the poor vascular reactivity, 1.0 ≤ VRI \< 2.0: the intermediate vascular reactivity, and VRI ≥ 2.0: the good vascular reactivity.

    pre-test and then every 3 months for 2 years

Study Arms (2)

Intradialytic exercise

EXPERIMENTAL

Cycling exercise 30 minutes a time, three times a week during hemodialysis

Other: Cycling exercise

Control group

NO INTERVENTION

not participate in cycling exercise during hemodialysis

Interventions

Intradialytic cycling exercise for 30 minutes a time

Intradialytic exercise

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Regular hemodialysis more than 3 months with 4 hours a time, thrice a week
  • Eligible to sign permit

You may not qualify if:

  • Could not sign permit or do not want to join the trial
  • Infection
  • Amputation of any one of the lower limb
  • Hemodynamic unstable
  • Acute myocardial infarction (AMI) in recent 6 months
  • Unstable heart condition, such as unstable angina, arrythmia
  • Deep vein thrombosis (DVT)
  • History of kidney transplantation
  • Vascular access over lower limb

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Buddhist Tzu Chi General Hospital

Hualien City, Taiwan

Location

MeSH Terms

Conditions

HemolysisMotor ActivitySleep Wake DisordersFatigue

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsBehaviorNervous System DiseasesNeurologic ManifestationsSigns and SymptomsMental Disorders

Study Officials

  • Yu-Hsien Lai

    Attending physician

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2019

First Posted

September 23, 2019

Study Start

January 1, 2018

Primary Completion

December 31, 2020

Study Completion

December 31, 2021

Last Updated

March 2, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations